Melanoma genomics – will we go beyond BRAF in clinics?
Abstract In the era of next-generation sequencing, the genetic background of cancer, including melanoma, appears to be thoroughly established. However, evaluating the oncogene BRAF mutation in codon V600 is still the only companion diagnostic genomic test commonly implemented in clinics for molecula...
Saved in:
Main Authors: | Justyna Mirek, Wiesław Bal, Magdalena Olbryt |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-09-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00432-024-05957-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining the high-risk category of patients with cutaneous melanoma: a practical tool based on prognostic modeling
by: Oleksandr Dudin, et al.
Published: (2025-02-01) -
The big challenge for livestock genomics is to make sequence data pay
by: Johnsson, Martin
Published: (2023-08-01) -
The large-scale whole-genome sequencing era expedited medical discovery and clinical translation
by: Qingxin Yang, et al.
Published: (2025-03-01) -
Right of reply - Response to: In defence of South Africa’s National Health Research Ethics Council guidelines on heritable human genome editing
by: M Ramsay, et al.
Published: (2025-02-01) -
Whole Genome Sequencing Reveals Substantial Genetic Structure and Evidence of Local Adaptation in Alaskan Red King Crab
by: Carl A. St. John, et al.
Published: (2025-01-01)